10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
In 2018, Governor Cuomo signed a State Budget bill that included various provisions addressing sexua...
Read More >
The Delaware courts have not been shy about warning of the dangers that can arise when merger negoti...
Read More >
The Employee Benefits Practice is pleased to present the Employee Benefits Developments Newsletter f...
Read More >
Unable to reach a last-minute deal with investors, rental car mainstay Hertz filed for bankruptcy la...
Read More >
On April 6, 2020, the Judicial Council of California (Council) adopted a court rule that tolled stat...
Read More >
SEC Chair Jay Clayton is reduced to having a PR firm create fake investor letters to support a SEC r...
Read More >